Guidelines 'Melanoma' (3rd revision);Richtlijn 'Melanoom' (3e herziening)

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 33, 2005, Pages 1839-1843

  Van Everdingen, J J E ^a   Van Der Rhee, H J ^b   Koning, C C E ^c   Nieweg, O E ^d   Kruit, W H J ^e   Coebergh, J W W ^f   Ruiter, D J ^g  

^a Dutch Institute for Healthcare Improvement CBO   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f The Netherlands   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE;

CANCER SURVIVAL; CLINICAL RESEARCH; CONGENITAL SKIN DISEASE; DISEASE MARKER; EPILUMINESCENCE MICROSCOPY; EVIDENCE BASED MEDICINE; HUMAN; MELANOMA; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN BIOPSY;

DERMATOLOGY; DERMOSCOPY; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HUMANS; MELANOMA; NETHERLANDS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 23844507741     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Kroon BBR, Bergman W, Coebergh JWW, Ruiter DJ. Tweede herziene consensus melanoom van de huid. Ned Tijdschr Geneeskd 1997;141:2015-9.
2. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002;3:159-65.
3. MacKie RM, Fleming C, McMahon AD, Jarrett P. The use of the dermatoscope to identify early melanoma using the three-colour test. Br J Dermatol 2002;146:481-4.
4. Bergman W. Dermatoscopie: een aanwinst voor de klinische beoordeling van gepigmenteerde afwijkingen. Ned Tijdschr Geneeskd 2002;146:1574-8.
5. Veenhuizen KC, Wit PE de, Mooi WJ, Scheffer E, Verbeek AL, Ruiter DJ. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party. J Pathol 1997;182:266-72.
6. Estourgie SH, Nieweg OE, Valdés Olmos RA, Hoefnagel CA, Kroon BBR. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681-8.
7. Koopal SA, Tiebosch AT, Piers DA, Plukker JT, Schraffordt Koops H, Hoekstra HJ. Frozen section analysis of sentinel lymph nodes in melanoma patients. Cancer 2000;89:1720-5.
8. Mahmood MN, Lee MW, Linden MD, Nathanson SD, Hornyak TJ, Zarbo RJ. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells. Mod Pathol 2002;15:1288-93.
9. Lens MB, Dawes M, Goodacre T, Bishop JA. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002;137:1101-5.
10. Haigh PI, DiFronzo LA, McCready DR. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg 2003;46:419-26.
11. Martin HM, Birkin AJ, Theaker JM. Malignant melanoma re-excision specimens - how many blocks? Histopathology 1998;32:362-7.
12. Wheatley K, Ives N, Hancock B, Gore M, Eggermont A, Suciu S. Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. Cancer Treat Rev 2003;29:241-52.
13. Crosby T, Fish R, Coles B, Mason MD. Systemic treatments for metastatic cutaneous melanoma [Cochrane review]. Cochrane Database Syst Rev 2000;(2):CD001215.